Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Exploration of Dabigatran in Atrial Fibrillation (PETRO)
NCT01227629Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2003
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of dabigatran in Atrial fibrillation (AFib), sponsored by Boehringer Ingelheim. Started Sep 2003; status: completed.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01227629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227629.